[The treatment of choice for recurrent ameloblastoma].

92 patients with recurring ameloblastoma of jawbones were followed. The result after submitting these patients under preserving surgical therapy were evaluated on the basis of compared biostatistical and bioclinical criterion. Among these 92 patients, 66 were Negro African series with a success rate of 82% and 26 others were white "Caucasian" series with a success rate of 85%.